Difference between revisions of "PCD Connectathon&Showcase 2009-09-22 Webex"

Revision as of 20:50, 22 September 2009

PCD Connectathon & Showcase WG Meeting September 22, 2009

Action Items

You can find the Action Items at http://spreadsheets.google.com/ccc?key=0AhUkNc_rKDnudFZKVUFrZEZQWmNBcU9RWnhVS0FCenc&hl=en

Agenda

Agendas will be found solely on the main page http://wiki.ihe.net/index.php?title=PCD_Connectathon%26Showcase_WG_2009-10#August_2009_Meetings.

Participants

Alex Beechie, Ruth Berge, Terry Bettis, Bikram Day, Allen Enebo, Al Engelbert, Robert Flanders, Ken Fuchs, Chad Hays, Sarah Hopkins, Brad Lunde, Michael Rice, Manny Furst

Discussion

Item	Topic	Discussion
1	Introductions & Agenda Review - Manny	Status/Discussion: No changes were made to the agenda Decisions/Issues: Action(s):
2	Review Discussion Summary	Status/Discussion: Accepted Decisions/Issues: Action(s):
3	Connectathon Planning -	Status/Discussion: We have a new Google Group for IDCO and they will transition to Webex for their meetings. Grouped actors: Vendors publicizing two actors that are grouped indicate that certain data is electronically transferred from one to the other, without manual action by the clinician. E.g., grouping the DOR actor with the IOC actor means that certain data is transferred from the IOC to the DOR (or vice-versa, as defined in the technical document). If these requirements are not met, they are not grouped. The profiles will need to be updated to reflect this. Testing this year will be updated to reflect this. PCD use of ADT: - Meetings last week addressed the questions of (1) Light Weight PAM and (2) grouping two actors. A meeting with ITI resulted in a decision to employ PAM (ITI-30 and/or ITI-31) and/or PDQ, as each vendor elects. Steve Moore noted that PDQ provides a snapshot, and if changes are required, the system will need to query periodically. He cautioned against too frequent queries and in a later email (following this WG meeting) suggested this could be done upon request by the clinician. - Ruth asked if there will be further discussion about PAM, PDQ. Robert responded that there are remaining questions – home health and some unique use cases. Ruth provided an example – what if the DOR and DOC are inconsistent? Ken noted that this is a very good question, and mismatches are likely since the various systems may not use the same ADT approach. Robert will have CPs later this week, but that won’t address the edge cases. Ken will add this to the agenda for the F2F. Decisions/Issues: Action(s):
4	Showcase Planning - Manny	Status/Discussion: Decisions/Issues: Action(s):
5	Action Items - Manny	Status/Discussion: Decisions/Issues: Action(s):
6	Issues and Questions - ___	Status/Discussion: Decisions/Issues: Action(s):
7	New Business - All	Status/Discussion: Decisions/Issues: Action(s):

Return to main WG page which has links to individual meeting pages

Return to main PCD Connectathon/Showcase WG page: PCD_Connectathon&Showcase_WG_2009-10

@@ Line 24: / Line 24: @@
 | '''Introductions & Agenda Review''' <br>- Manny
 | '''Status/Discussion:'''
-: No changes were made to the agenda  '''placeholder'''
+: No changes were made to the agenda
 '''Decisions/Issues:'''
@@ Line 34: / Line 34: @@
 | '''Review Discussion Summary'''
 | '''Status/Discussion:'''
-:* Accepted   '''placeholder'''
+:* Accepted
 '''Decisions/Issues:'''
@@ Line 44: / Line 44: @@
 | '''Connectathon Planning''' <br>-
 | '''Status/Discussion:'''
+:* We have a new Google Group for IDCO and they will transition to Webex for their meetings.
+:* Grouped actors: Vendors publicizing two actors that are grouped indicate that certain data is electronically transferred from one to the other, without manual action by the clinician. E.g., grouping the DOR actor with the IOC actor means that certain data is transferred from the IOC to the DOR (or vice-versa, as defined in the technical document). If these requirements are not met, they are not grouped. The profiles will need to be updated to reflect this. Testing this year will be updated to reflect this.
+:* PCD use of ADT:
+::- Meetings last week addressed the questions of (1) Light Weight PAM and (2) grouping two actors. A meeting with ITI resulted in a decision to employ PAM (ITI-30 and/or  ITI-31) and/or PDQ, as each vendor elects. Steve Moore noted that PDQ provides a snapshot, and if changes are required, the system will need to query periodically. He cautioned against too frequent queries and in a later email (following this WG meeting) suggested this could be done upon request by the clinician.
+::- Ruth asked if there will be further discussion about PAM, PDQ. Robert responded that there are remaining questions – home health and some unique use cases. Ruth provided an example – what if the DOR and DOC are inconsistent? Ken noted that this is a very good question, and mismatches are likely since the various systems may not use the same ADT approach. Robert will have CPs later this week, but that won’t address the edge cases. Ken will add this to the agenda for the F2F.
 :*
+:*
+:*
 '''Decisions/Issues:'''